Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults

Autor: Banda, CG, Dzinjalamala, F, Mukaka, M, Mallewa, J, Maiden, V, Terlouw, DJ, Lalloo, DG, Khoo, SH, Mwapasa, V

Publikováno v: Antimicrobial Agents and Chemotherapy

There are limited data on the pharmacokinetic and safety profiles of artesunate-amodiaquine in human immnunodeficiency virus-infected (HIV+) individuals receiving antiretroviral therapy. In a two-step intensive sampling pharmacokinetic trial, we comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6c50a331b6b2f01e99352b10f8ec6ae1
https://doi.org/10.1128/aac.00412-18

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

Autor: Sevene, E, Banda, CG, Mukaka, M, Maculuve, S, Macuacua, S, Vala, A, Piqueras, M, Kalilani-Phiri, L, Mallewa, J, Terlouw, DJ, Khoo, SH, Lalloo, DG, Mwapasa, V

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
Malaria Journal, Vol 18, Iss 1, Pp 1-13 (2019)
MALARIA JOURNAL
Malaria Journal
Dipòsit Digital de la UB
Universidad de Barcelona

Background HIV-infected individuals on antiretroviral therapy (ART) require treatment with artemisinin-based combination therapy (ACT) when infected with malaria. Dihydroartemisinin–piperaquine (DPQ) is recommended for treatment of Plasmodium falci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::16e9fa280dd6cf1347e5cc79ed628302
http://hdl.handle.net/2445/149239

Pharmacokinetics of Single-Dose Versus Double-Dose Dolutegravir After Switching From a Failing Efavirenz-Based Regimen.

Autor: Griesel R; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Banda CG; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Zhao Y; Department of Medicine, University of Cape Town, Cape Town, South Africa ; and., Omar Z; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Department of Medicine, University of Cape Town, Cape Town, South Africa ; and., Sinxadi P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Platform for Pharmacogenomics Research and Translation (PREMED), University of Cape Town, South African Medical Research Council, Cape Town, South Africa ., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 May 01; Vol. 96 (1), pp. 85-91.

Association between HIV and treatment-resistant hypertension in Malawian adults: a protocol for a case-control study.

Autor: Gondwe J; Population Health Theme, Malawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi., Ndovie M; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi., Khuluza F; Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi., Banda CG; Population Health Theme, Malawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi cgbanda@mlw.mw.

Publikováno v: BMJ open [BMJ Open] 2023 Aug 02; Vol. 13 (8), pp. e069280. Date of Electronic Publication: 2023 Aug 02.

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV.

Autor: Mondleki E; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Banda CG; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Chandiwana NC; Ezintsha, University of the Witwatersrand, Johannesburg, South Africa., Sokhela S; Ezintsha, University of the Witwatersrand, Johannesburg, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Venter F; Ezintsha, University of the Witwatersrand, Johannesburg, South Africa., Maartens G; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Sinxadi PZ; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Publikováno v: Southern African journal of HIV medicine [South Afr J HIV Med] 2022 Dec 13; Vol. 23 (1), pp. 1452. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).